Clinical trials for Remdesivir are ongoing. There are some problems with the Chinese trials, which were the first to start twenty days ago: https://clinicaltr

Clinical trials for Remdesivir are ongoing. There are some problems with the Chinese trials, which were the first to start twenty days ago: https://clinicaltrials.gov/ct2/show/NCT04252664 https://clinicaltrials.gov/ct2/show/NCT04252664 https://clinicaltrials.gov/ct2/show/NCT04257656 https://clinicaltrials.gov/ct2/show/NCT04257656 Trials were run in Wuhan by popular demand but the epicenter with a very over-burdened medical system was probably not the best choice as trial site. Recruitment of mild/moderate cases were particularly problematic because these were not treated in hospitals in Wuhan at that time (you had to have a serious enough case to have a real hospital bed). It is also hard to find patients who have not tried other medication per the recruitment criteria. The US organized trial https://clinicaltrials.gov/ct2/show/NCT04280705 https://clinicaltrials.gov/ct2/show/NCT04280705 just started but is designed to be a lot more flexible and will show results a lot sooner if Remdesivir is actually as effective as we all hope it to be.